Eur Eat Disord Rev 30:301303 Balodis IM, Grilo CM, Potenza MN (2015) Neurobiological features of binge eating disorder
Dose modeling research suggested that patients might receive even more benefits with little extra risk at a 7.2 mg dose, a concept that was tested in the STEP UP trials (STEP UP Obesity and STEP UP Diabetes)
Some people also report a lower sense of thirst, so they may not drink enough during the day
But over time, the brain becomes used to the presence of the drug and cant function normally without it
The increased risk of angioedema with combination DPP-4 and ACE inhibitor therapy is one potential limitation [214], however, this issue may be managed by consideration of replacing an ACE inhibitor with an ARB [128, 215]
It packs twice the semaglutide per milliliter compared to the 5mg/mL vial